Search

Displaying results 2401 - 2410 of 10000 in total

Drug
Tofogliflozin
go.drugbank.com/drugs/DB11824
Investigational
Tofogliflozin has been used in trials studying the treatment and prevention of Diabetes Mellitus Type 2.
Categories: Sodium-Glucose Transporter 2 Inhibitors
Drug
Ruboxistaurin
go.drugbank.com/drugs/DB11829
Investigational
Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
Drug
Crenolanib
go.drugbank.com/drugs/DB11832
Investigational
Crenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
Drug
Lucitanib
go.drugbank.com/drugs/DB11845
Investigational
Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Categories: Heterocyclic Compounds, 2-Ring
Drug
Bafetinib
go.drugbank.com/drugs/DB11851
Investigational
Bafetinib has been used in trials studying the treatment of Adult Gliosarcoma, Adult Mixed Glioma, Adult Glioblastoma, Chronic Myeloid Leukemia, and Acute Lymphocytic Leukemia, among others.
Categories: Heterocyclic Compounds, 1-Ring
Drug
Tegobuvir
go.drugbank.com/drugs/DB11852
Investigational
Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
Drug
Relugolix
go.drugbank.com/drugs/DB11853
ApprovedInvestigational
Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of several hormone-responsive conditions. … [A225761] Relugolix is the first (and currently only) orally-administered GnRH receptor antagonist approved for the treatment of prostate cancer - similar therapies such as [degarelix] require subcutaneous
Categories: P-glycoprotein inhibitors, P-glycoprotein substrates
Drug
Brexanolone
go.drugbank.com/drugs/DB11859
ApprovedInvestigational
As of March 2019, brexanolone - developed and made available commercially by Sage Therapeutics Inc. as the brand name product Zulresso - is the first drug to have ever been approved by the US FDA specifically … Since PPD, like various other types of depression, is characterized by feelings of sadness, worthlessness or guilt, cognitive impairment, and/or possibly suicidal ideation, it is considered a life-threatening
Categories: Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator, Neuroactive Steroid Gamma-Aminobutyric Acid (GABA) A Receptor Positive Modulators
Drug
Alvelestat
go.drugbank.com/drugs/DB11863
Investigational
Alvelestat has been investigated for the basic science of Chronic Obstructive Pulmonary Disease.
Categories: Heterocyclic Compounds, 1-Ring
Drug
JNJ-39393406
go.drugbank.com/drugs/DB11867
Investigational
JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia, Smoking Cessation, Cognition Disorders, and Alzheimer's Disease.
Categories: Heterocyclic Compounds, 1-Ring